INOZYME PHARMA INC shareholders Q2 2023

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 74 filers reported holding INOZYME PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.65 and the average weighting 0.2%.

INOZYME PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 26,305$146,5190.00%
BARCLAYS PLC 10,205$560.00%
ROYAL BANK OF CANADA 3,940$22,0000.00%
VANGUARD GROUP INC 1,395,910$7,775,2180.00%
VOYA INVESTMENT MANAGEMENT LLC 13,685$76,2250.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 11,260$62,7180.00%
UBS Group AG 21,577$120,1840.00%
RHUMBLINE ADVISERS 43,411$241,7990.00%
NewEdge Advisors, LLC 381$2,1210.00%
FMR LLC 748,834$4,171,0050.00%
DIMENSIONAL FUND ADVISORS LP 83,196$463,3480.00%
BANK OF AMERICA CORP /DE/ 55,503$309,1520.00%
WELLS FARGO & COMPANY/MN 12,840$71,5190.00%
NORTHERN TRUST CORP 300,383$1,673,1330.00%
AMERICAN CENTURY COMPANIES INC 12,200$67,9540.00%
Nuveen Asset Management, LLC 137,749$767,2620.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 14,690$81,8230.00%
GROUP ONE TRADING, L.P. 2,109$11,7470.00%
Legal & General Group Plc 3,255$18,1300.00%
External links

This page lists INOZYME PHARMA INC's shareholders in Q2 2023. To view INOZYME PHARMA INC's shareholder history, click here.